β-glucosidase Antibody (B-6) is a high quality monoclonal beta-glucosidase antibody (also designated GBA antibody, GLCM antibody, Glucosylceramidase Beta antibody, D-Glucosyl-N-Acylsphingosine Glucohydrolase antibody, Cholesterol Glucosyltransferase antibody, Cholesteryl-Beta-Glucosidase antibody, Glucosidase Beta Acid antibody, Beta-Glucocerebrosidase antibody, Acid Beta-Glucosidase antibody, Lysosomal Acid GCase antibody, Imiglucerase antibody, Alglucerase antibody, Beta-GC antibody, SGTase antibody, GBA1 antibody, GLUC antibody, Lysosomal Glucocerebrosidase antibody, Glucosylceramidase antibody, or GCB antibody) suitable for the detection of the beta-glucosidase protein of mouse, rat and human origin. β-glucosidase Antibody (B-6) is available as both the non-conjugated anti-beta-glucosidase antibody form, as well as multiple conjugated forms of anti-beta-glucosidase antibody, including agarose, HRP, PE, FITC and multiple Alexa Fluor® conjugates. β-Glucosidase is a predominantly liver enzyme which efficiently hydrolyzes β-D-glucoside and β-D-galactoside. Defects in β-Glucosidase cause Gaucher disease, an inherited condition distinguished by the accumulation of glucosylceramide within the cells of the reticuloendothelial system. β-Glucosidase is used in enzyme replacement treatment aimed at treating Gaucher disease. The absorption of dietary flavonoid glycosides in humans involves a critical deglycosylation step that is mediated by epithelial β-glucosidases.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA
LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences